(1) Background: Respiratory co-infections with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and other viruses are common, but data on clinical outcomes …

Background: We aimed to compare the clinical severity in patients who were coinfected with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and rhinovirus or …

Background Although the clinical course of the COVID-19 in adults has been extensively
described, the impact of the co-detection of SARS-CoV-2 and rhinovirus on severity …

Background Previous studies have shown that non-critically ill COVID-19 patients co-
infected with other respiratory viruses have poor clinical outcomes. However, limited studies …

Infection with the new pandemic pathogen severe acute respiratory syndrome coronavirus‐2
(SARS‐CoV‐2) can cause a wide range of disease varying from mild cold‐like symptoms to …

Aims During the ongoing COVID-19 outbreak, co-circulation of other common respiratory
viruses can potentially result in co-infections; however, reported rates of co-infections for …

Although a few studies comparing severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and non-SARS-CoV-2 respiratory viruses have been reported, clinical features and …

Background: Co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) with respiratory viruses, bacteria and fungi have been reported to cause a wide range of …

Background In COVID-19 patients undetected co-infections may have severe clinical
implications associated with prolonged hospitalization, ICU admission, and mortality …

Introduction This study aimed to determine the prevalence, viral profile, and clinical features
of coinfections with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and …